Information Provided By:
Fly News Breaks for May 1, 2015
PCRX
May 1, 2015 | 07:16 EDT
Brean Capital lowered its price target on Pacira to $92 from $121 citing a reduced revenue forecast due to a lack of visibility. Brean Capital reiterated its Buy rating on Pacira shares.
News For PCRX From the Last 2 Days
There are no results for your query PCRX